Built by Nature, a network and grant-making fund, has announced a global prize totalling EUR500,000 to recognise innovation and stimulate scalability in the use of biobased materials such as timber, bamboo, hemp, straw, algae, and fungi in
China Digest: Biopharma startup Alebund raises $60m; Revere VC closes seed round
May 11, 2021
Chinese biopharmaceutical startup Alebund Pharmaceuticals has secured $60 million in a Series B round, while San Francisco and Hong Kong-based asset management firm Revere VC has closed its seed round.
Alebund Pharma nets $60m in Series B round
Alebund Pharmaceuticals, a biopharmaceutical startup that develops innovative therapies for the treatment of renal diseases, has bagged $60 million in a Series B round of financing, the startup announced on May 9.
The Series B round was led by Quan Capital, a life sciences venture capital (VC) firm, with participation from an unspecified sovereign wealth fund; 3E Bioventures Capital, an investor of life sciences and biomedical technologies; and healthcare investment platform Sherpa Healthcare Partners.
Click HERE to find out ⭐ Revere VC Raises $1.35 Million Seed Round, Launches Curated VC Platform - "the Portal". | Crowdfund Insider: Global Fintech News, including Crowdfunding, Blockchain and more.